506 related articles for article (PubMed ID: 37534206)
1. Role of extracellular vesicles in nonalcoholic fatty liver disease.
Jiang W; Xu Y; Chen JC; Lee YH; Hu Y; Liu CH; Chen E; Tang H; Zhang H; Wu D
Front Endocrinol (Lausanne); 2023; 14():1196831. PubMed ID: 37534206
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
[TBL] [Abstract][Full Text] [Related]
3. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
Villard A; Boursier J; Andriantsitohaina R
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G485-G495. PubMed ID: 33471632
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.
Jiang F; Chen Q; Wang W; Ling Y; Yan Y; Xia P
J Hepatol; 2020 Jan; 72(1):156-166. PubMed ID: 31568800
[TBL] [Abstract][Full Text] [Related]
5. [Value of detection of extracellular vesicles in the diagnosis of nonalcoholic fatty liver disease].
Jiang WY; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):92-96. PubMed ID: 32023709
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease.
Jiang H; Qian Y; Shen Z; Liu Y; He Y; Gao R; Shen M; Chen S; Fu Q; Yang T
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955511
[TBL] [Abstract][Full Text] [Related]
7. Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets.
Yang L; Hao Y; Boeckmans J; Rodrigues RM; He Y
Pharmacol Ther; 2023 Mar; 243():108353. PubMed ID: 36738973
[TBL] [Abstract][Full Text] [Related]
8. Human milk-derived extracellular vesicles alleviate high fat diet-induced non-alcoholic fatty liver disease in mice.
Jiang X; Wu Y; Zhong H; Zhang X; Sun X; Liu L; Cui X; Chi X; Ji C
Mol Biol Rep; 2023 Mar; 50(3):2257-2268. PubMed ID: 36575319
[TBL] [Abstract][Full Text] [Related]
9. The promise of small particles: extracellular vesicles as biomarkers in liver pathology.
Srinivas AN; Suresh D; Kaur S; Kumar DP
J Physiol; 2023 Nov; 601(22):4953-4971. PubMed ID: 35708653
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles as Biomarkers in Liver Disease.
Muñoz-Hernández R; Rojas Á; Gato S; Gallego J; Gil-Gómez A; Castro MJ; Ampuero J; Romero-Gómez M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555854
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.
Ban LA; Shackel NA; McLennan SV
Int J Mol Sci; 2016 Mar; 17(3):376. PubMed ID: 26985892
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.
Szabo G; Momen-Heravi F
Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):455-466. PubMed ID: 28634412
[TBL] [Abstract][Full Text] [Related]
13. Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis.
Garcia-Martinez I; Alen R; Rada P; Valverde AM
Front Med (Lausanne); 2020; 7():395. PubMed ID: 32850903
[TBL] [Abstract][Full Text] [Related]
14. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.
Povero D; Eguchi A; Li H; Johnson CD; Papouchado BG; Wree A; Messer K; Feldstein AE
PLoS One; 2014; 9(12):e113651. PubMed ID: 25470250
[TBL] [Abstract][Full Text] [Related]
15. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
[TBL] [Abstract][Full Text] [Related]
16. Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues.
Li CJ; Fang QH; Liu ML; Lin JN
Theranostics; 2020; 10(16):7422-7435. PubMed ID: 32642003
[TBL] [Abstract][Full Text] [Related]
17. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
[TBL] [Abstract][Full Text] [Related]
18. The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles.
Moayedfard Z; Sani F; Alizadeh A; Bagheri Lankarani K; Zarei M; Azarpira N
Stem Cell Res Ther; 2022 Jun; 13(1):242. PubMed ID: 35672797
[TBL] [Abstract][Full Text] [Related]
19. Iron-loaded extracellular vesicles: angel or demon?
Chen H; Tang Y
Free Radic Res; 2023 Jan; 57(1):61-68. PubMed ID: 36927327
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.
Eguchi A; Iwasa M; Nakagawa H
Liver Int; 2023 Feb; 43(2):292-298. PubMed ID: 36462157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
